Selective reduction and homologation of carbon monoxide by organometallic iron complexes

Nature Communications
Helen R SharpeDeborah L Kays

Abstract

Carbon monoxide is a key C1 feedstock for the industrial production of hydrocarbons, where it is used to make millions of tonnes of chemicals, fuels, and solvents per annum. Many transition metal complexes can coordinate CO, but the formation of new C-C bonds in well-defined compounds from the scission and subsequent coupling of two or more CO moieties at a transition metal centre remains a challenge. Herein, we report the use of low-coordinate iron(II) complexes for the selective scission and homologation of CO affording unusual squaraines and iron carboxylates at ambient temperature and pressure. A modification of the ligand framework allows for the isolation and structural characterisation of a proposed metallacyclic Fe(II) carbene intermediate. These results indicate that, with the appropriate choice of supporting ligands, it is possible to cleave and homologate carbon monoxide under mild conditions using an abundant and environmentally benign low-coordinate, first row transition metal.

References

Dec 8, 2005·Journal of the American Chemical Society·Tsukasa Matsuo, Hiroyuki Kawaguchi
Feb 20, 2007·Dalton Transactions : an International Journal of Inorganic Chemistry·Lei YangRobert P Houser
Feb 28, 2007·Chemical Communications : Chem Comm·Deborah L Kays, Andrew R Cowley
Mar 28, 2007·Chemistry : a European Journal·Gemma ChristianChristopher C Cummins
Oct 16, 2008·Inorganic Chemistry·Hao LeiPhilip P Power
Feb 27, 2009·Journal of the American Chemical Society·Takahito WatanabeHiroyuki Kawaguchi
May 6, 2009·Journal of the American Chemical Society·Xinping WangPhilip P Power
Sep 16, 2009·Chemical Communications : Chem Comm·Chengbao Ni, Philip P Power
Mar 8, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·David Benito-GaragorriKarl A Kirchner
Apr 1, 2010·Journal of Applied Crystallography·Ian R ThomasPeter A Wood
Jun 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Benedict M GardnerStephen T Liddle
Aug 1, 2012·Chemical Communications : Chem Comm·Benjamin M GridleyDeborah L Kays
Dec 14, 2012·Dalton Transactions : an International Journal of Inorganic Chemistry·Takashi KurogiHiroyuki Kawaguchi
Aug 13, 2013·Journal of the American Chemical Society·Daniel L M Suess, Jonas C Peters
Nov 22, 2013·Nature Chemistry·Holger BraunschweigAlfredo Vargas
Jun 20, 2015·Angewandte Chemie·Moumita MajumdarDavid Scheschkewitz
Jun 24, 2016·Chemistry : a European Journal·Vito MalteseRené A J Janssen
Oct 31, 2017·Journal of the American Chemical Society·Baoli WangZhaomin Hou

❮ Previous
Next ❯

Citations

May 1, 2019·Chemical Communications : Chem Comm·Ravi YadavPeter W Roesky
Jul 30, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Laurence J Taylor, Deborah L Kays
Jun 13, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Richard Y Kong, Mark R Crimmin
Jul 22, 2020·Chemical Communications : Chem Comm·Toby J BlundellDeborah L Kays
Jul 2, 2021·Inorganic Chemistry·Yu LiuDeborah L Kays
Jul 29, 2021·Chemical Communications : Chem Comm·Sui HasegawaHiroyuki Kawaguchi
Jul 29, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Ruth WellerC Gunnar Werncke
Nov 20, 2020·The Journal of Physical Chemistry. a·Patricio LimonMiguel Castro
May 18, 2019·Journal of the American Chemical Society·K YuvarajCameron Jones
Sep 3, 2021·The Journal of Physical Chemistry. a·Patricio LimonMiguel Castro
Sep 16, 2021·Journal of the American Chemical Society·Jun OhataHiroyuki Matsuzaka
Dec 8, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Christian SchneiderC Gunnar Werncke

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
NMR

Software Mentioned

RASSCF

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.